Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Idogen AB

IDOGEN
Current price
0.12 SEK -0.00000000015 SEK (0.00%)
Last closed 0.12 SEK
ISIN SE0014428561
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Stockholm Exchange
Capitalization 12 701 033 SEK
Yield for 12 month 0.00 %
1Y
3Y
5Y
10Y
15Y
IDOGEN
21.11.2021 - 28.11.2021

Idogen AB (publ), a biotechnology company, develops tolerogenic cell therapies to prevent the patient's immune system from attacking biological agents, transplanted organs, and the body's own cells or tissues in Sweden. The company's advanced product candidate is IDO 8 that is designed for patients with severe haemophilia A, who have developed neutralizing antibodies against critical treatment with coagulation factor VIII. It also develops IDO T, a tolerogenic cell therapy to prevent organ transplant rejection primarily kidney transplantation; and IDO AID for the treatment of autoimmune diseases. The company was incorporated in 2008 and is headquartered in Lund, Sweden. Address: Medicon Village, Lund, Sweden, 223 81

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.51 SEK

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures IDOGEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -42 625 200 SEK
Operating Margin TTM -5671.86 %
PE Ratio
Return On Assets TTM -106.79 %
PEG Ratio
Return On Equity TTM -202.71 %
Wall Street Target Price 0.51 SEK
Revenue TTM 765 883 SEK
Book Value 0.019 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -92.3 %
Dividend Yield
Gross Profit TTM 411 252 SEK
Earnings per share -0.38 SEK
Diluted Eps TTM -0.38 SEK
Most Recent Quarter I 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IDOGEN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IDOGEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 27.05.2020
Dividend Date

Stock Valuation IDOGEN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 3.7124
Enterprise Value EBITDA -0.2253
Price Book MRQ 6.1865

Financials IDOGEN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IDOGEN

For 52 weeks

0.12 SEK 0.12 SEK
50 Day MA 0.12 SEK
Shares Short Prior Month
200 Day MA 0.12 SEK
Short Ratio
Shares Short
Short Percent